JOHNS HOPKINS UNIVERSITY
Molecular and structural characterization of broadly neutralizing anti-HCV antibodies
Molecular and structural characterization of broadly neutralizing anti-HCV antibodies is a funding opportunity from JOHNS HOPKINS UNIVERSITY, up to 804923, closing January 31, 2028.
Jan 31, 2028
(549d left)Overview
Summary More than 70 million people worldwide are infected with hepatitis C virus (HCV), and development of a vaccine for HCV is essential for disease eradication. Although direct-acting antivirals are highly effective for treatment, the majority of countries surveyed are not on track to reach the WHO goal of…